PureTech Health plc

PRTCNASDAQHealthcare● Active

$17.42

+$0.17(+0.99%)

Market Cap$424066836

P/E Ratio—

52W High$19.92

52W Low$14.5

Avg Volume9K

Open$17.44

Beta0.79

Free Cash Flow Financials Revenue

PureTech Health plc (PRTC) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

PRTC · free cash flow · updated Jun 8, 2026

Core FCF metrics

PRTC · FCF · TTM · margin & CAGR

Free cash flow was −$85.3M for FY2025 (fiscal year ending 2025-12-31), up 36.5% year-over-year

FY2025 Free Cash Flow−$85.3M▲ +36.5% YoY

Trailing 12M (TTM)−$219.2Mtrailing 4 quarters sum

FCF Margin< −999%−$85.3M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

PRTC · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$85.3M(0M)−$85.3M▲ +36.5%—

FY2024−$134.4M(0M)−$134.4M▼ 26.6%—

FY2023−$105.9M(0M)−$106.2M▲ +41.3%—

FY2022−$178.8M(2M)−$181.0M▼ 10.4%—

FY2021−$158.3M(6M)−$163.9M▼ 19.4%—

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

PRTC · P/FCF · FCF yield · FCF per share

PureTech Health plc (PRTC) reported negative free cash flow of −$0.09B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

PRTC · cash flow statement · operating / investing / financing

For FY2025, PureTech Health plc generated −$85.3M in operating cash flow and spent 0M in capital expenditures, yielding −$85.3M in free cash flow.

Operating Activities

−$85.3M

Cash from core business operations

2025-12-31

Investing Activities

+$63.4M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$6.3M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$85.3M) − |CapEx| (0M) = FCF (−$85.3M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

PRTC vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

PureTech Health plcYOU

PRTC

−$85.3M+36.5%-1831.6%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

PureTech Health plc (PRTC) reported free cash flow of −$85.3M for FY2025 (fiscal year ending 2025-12-31), up 36.5% year-over-year.

PureTech Health plc has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 14 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

PRTC free cash flow · 8 questions

PureTech Health plc free cash flow was −$85.3M for FY2025, up 36.5% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$219.2M.

PRTC free cash flowPRTC FCFPRTC FCF 2025PRTC free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · PureTech Health plc · PureTech Health plc SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026